Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer

Objectives. To compare pathologic outcomes after treatment with gemcitabine and cisplatin (GC) versus methotrexate, vinblastine, adriamycin, and cisplatin (MVAC) in the neoadjuvant setting. Methods. Data was retrospectively collected on 178 patients with T2-T4 bladder cancer who underwent radical cy...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Franklin C., Harris, William, Cheng, Heather H., Shenoi, Jaideep, Zhao, Song, Wang, Junfeng, Champion, Thomas, Izard, Jason, Gore, John L., Porter, Michael, Yu, Evan Y., Wright, Jonathan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871504/
https://www.ncbi.nlm.nih.gov/pubmed/24382958
http://dx.doi.org/10.1155/2013/317190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871504/
https://www.ncbi.nlm.nih.gov/pubmed/24382958
http://dx.doi.org/10.1155/2013/317190

Ejemplares similares